Innospec, Inc. Hits 52-Week Low at $67.37 Amid Significant Decline

Innospec, Inc., a small-cap player in the Chemicals & Petrochemicals industry, has reached a new 52-week low of USD 67.37 on March 18, 2026. This significant decline marks a challenging period for the company, which has seen its stock price drop by 45.76% over the past year, contrasting sharply with the S&P 500's performance of 17.99% during the same timeframe. The company's market capitalization stands at USD 2,022 million, with a price-to-earnings (P/E) ratio of 14.00. Innospec's dividend yield is notably high at 1,051.30%, reflecting its commitment to returning value to shareholders despite recent performance challenges. The firm has a debt-to-equity ratio of -0.21, indicating a conservative approach to leverage. In terms of profitability, Innospec reported a return on equity (ROE) of 10.91%, with a price-to-book ratio of 1.52. However, the company has faced difficulties, as evidenced by a decline in net profit and operating cash flow. With institutional holdings at 100%, Innospec's stock remains under scrutiny as it navigates a period of consistent underperformance against market benchmarks.